Petros Pharmaceuticals, Inc. (PTPI)
USD 0.05
(-3.36%)
USD 0.05
(-3.36%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 8.27 Million USD | -15.03% |
| 2022 | 9.74 Million USD | 2304.94% |
| 2021 | 405.01 Thousand USD | -94.36% |
| 2020 | 7.17 Million USD | -47.79% |
| 2019 | 13.74 Million USD | -70.88% |
| 2018 | 47.19 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 7.63 Million USD | -4.74% |
| 2024 Q1 | 8.01 Million USD | -3.17% |
| 2023 Q1 | 9.34 Million USD | -4.08% |
| 2023 FY | 8.27 Million USD | -15.03% |
| 2023 Q3 | 8.68 Million USD | -2.82% |
| 2023 Q2 | 8.94 Million USD | -4.32% |
| 2023 Q4 | 8.27 Million USD | -4.74% |
| 2022 Q3 | 9.96 Million USD | -3.84% |
| 2022 Q2 | 10.36 Million USD | -2.0% |
| 2022 FY | 9.74 Million USD | 2304.94% |
| 2022 Q1 | 10.57 Million USD | 2510.45% |
| 2022 Q4 | 9.74 Million USD | -2.23% |
| 2021 Q1 | 5.06 Million USD | -29.46% |
| 2021 FY | 405.01 Thousand USD | -94.36% |
| 2021 Q4 | 405.01 Thousand USD | -81.41% |
| 2021 Q3 | 2.17 Million USD | -36.4% |
| 2021 Q2 | 3.42 Million USD | -32.32% |
| 2020 Q4 | 7.17 Million USD | -71.24% |
| 2020 FY | 7.17 Million USD | -47.79% |
| 2020 Q3 | 24.94 Million USD | 14.67% |
| 2020 Q2 | 21.75 Million USD | 36.88% |
| 2020 Q1 | 15.89 Million USD | 10.51% |
| 2019 Q4 | 14.38 Million USD | 0.0% |
| 2019 FY | 13.74 Million USD | -70.88% |
| 2019 Q1 | - USD | 0.0% |
| 2018 FY | 47.19 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 674.28 Million USD | 98.773% |
| Embecta Corp. | 1.63 Billion USD | 99.495% |
| ANI Pharmaceuticals, Inc. | 315.32 Million USD | 97.375% |
| Dynavax Technologies Corporation | 256.91 Million USD | 96.778% |
| Esperion Therapeutics, Inc. | 540.94 Million USD | 98.47% |
| Pacira BioSciences, Inc. | 586.04 Million USD | 98.588% |
| PainReform Ltd. | 86 Thousand USD | -9523.943% |
| Aquestive Therapeutics, Inc. | 98.82 Million USD | 91.625% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -1158.405% |
| SCYNEXIS, Inc. | 15.08 Million USD | 45.115% |
| China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -212.624% |
| Cosmos Health Inc. | 12.42 Million USD | 33.382% |
| Journey Medical Corporation | 17.73 Million USD | 53.319% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -1158.405% |
| Safety Shot Inc | 1.54 Million USD | -434.327% |
| Alpha Teknova, Inc. | 30.45 Million USD | 72.826% |
| Intra-Cellular Therapies, Inc. | 16.93 Million USD | 51.136% |
| Bright Green Corporation | 1.85 Million USD | -346.953% |
| Procaps Group, S.A. | 285.93 Million USD | 97.105% |
| Theratechnologies Inc. | 58.96 Million USD | 85.964% |
| Harrow Health, Inc. | 190.5 Million USD | 95.655% |
| Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -1261.281% |
| Biofrontera Inc. | 5.39 Million USD | -53.299% |
| DURECT Corporation | 20.74 Million USD | 60.105% |
| Supernus Pharmaceuticals, Inc. | 41.52 Million USD | 80.069% |
| Cronos Group Inc. | 2.53 Million USD | -225.858% |
| OptiNose, Inc. | 131.74 Million USD | 93.718% |
| Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 98.843% |
| Kala Pharmaceuticals, Inc. | 36.32 Million USD | 77.214% |
| RedHill Biopharma Ltd. | 1.17 Million USD | -605.588% |
| Organogenesis Holdings Inc. | 119.35 Million USD | 93.065% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 18.42 Million USD | 55.088% |
| Radius Health, Inc. | 365.31 Million USD | 97.734% |
| Universe Pharmaceuticals INC | 5.48 Million USD | -50.965% |
| ProPhase Labs, Inc. | 21.38 Million USD | 61.288% |
| Phibro Animal Health Corporation | 525.45 Million USD | 98.425% |
| Procaps Group S.A. | 285.93 Million USD | 97.105% |
| Alvotech | 1.07 Billion USD | 99.23% |
| TherapeuticsMD, Inc. | 8 Million USD | -3.393% |
| Viatris Inc. | 18.12 Billion USD | 99.954% |
| Rockwell Medical, Inc. | 13.43 Million USD | 38.414% |
| Aytu BioPharma, Inc. | 15.12 Million USD | 45.293% |
| SIGA Technologies, Inc. | 1.46 Million USD | -465.337% |
| Tilray Brands, Inc. | 387.31 Million USD | 97.863% |
| Lifecore Biomedical, Inc. | 130.36 Million USD | 93.651% |
| Shineco, Inc. | 29.65 Million USD | 72.092% |
| PetIQ, Inc. | 468.3 Million USD | 98.233% |
| Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -13738.833% |
| Incannex Healthcare Limited | 373 Thousand USD | -2118.925% |
| Neurocrine Biosciences, Inc. | 428.4 Million USD | 98.068% |
| Alimera Sciences, Inc. | 67.39 Million USD | 87.72% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 40.91 Million USD | 79.77% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -660.93% |
| Clever Leaves Holdings Inc. | 2.08 Million USD | -296.578% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -701.13% |
| Avadel Pharmaceuticals plc | 35.38 Million USD | 76.609% |
| Hempacco Co., Inc. | 13.72 Million USD | 39.695% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.07 Billion USD | 99.23% |
| Eagle Pharmaceuticals, Inc. | 62.46 Million USD | 86.75% |
| Lantheus Holdings, Inc. | 616.94 Million USD | 98.658% |
| Currenc Group, Inc. | 31.94 Million USD | 74.09% |
| Kamada Ltd. | 8.74 Million USD | 5.399% |
| Indivior PLC | 281.6 Million USD | 97.061% |
| Evoke Pharma, Inc. | 5 Million USD | -65.532% |
| Flora Growth Corp. | 3.67 Million USD | -125.397% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -701.13% |
| Evolus, Inc. | 126.54 Million USD | 93.46% |
| HUTCHMED (China) Limited | 86.13 Million USD | 90.391% |
| Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 98.673% |
| Akanda Corp. | 3.99 Million USD | -106.977% |